To view this email as a web page, click here

Today's Rundown

Featured Story

With the Olympics just months away, Japan issues emergency nod for AstraZeneca, Moderna vaccines

Japan, which has fallen far behind other wealthy nations when it comes to its COVID-19 vaccine rollout, approved the emergency use of shots from AstraZeneca and Moderna. The move comes just months ahead of the already-postponed Olympic Games.

read more

Top Stories

Most nursing homes faced multiple, persistent outbreaks of COVID-19 among residents and staff, GAO reports

U.S. nursing homes were repeat victims of the COVID-19 pandemic with about 94% experiencing two or more outbreaks of the disease among residents or staff through January, a new report from the U.S. Government Accountability Office reveals.

read more

Novavax hunts for Australian manufacturer as CSL homes in on AstraZeneca vaccine production

Once a likely contender to produce Novavax's late-stage COVID-19 vaccine in Australia, local biotech CSL now says it'll be too busy manufacturing AstraZeneca's shot. Novavax, meanwhile, is in the "early stages" of a search for long-term production.

read more

COVID-19 tracker: U.S. eases export controls for CureVac shot: report; White House partners with dating apps to push vaccines

European Union officials have persuaded the U.S. to loosen some of its export controls on key vaccine supplies so Germany's CureVac can manufacture its shot, sources tell Reuters. The Biden administration wants lonely singles to swipe right on the COVID-19 vaccine. And more headlines.

read more

Pandemic fallout: Pharma execs should discard conservative playbook, take aggressive action, says report

The coronavirus pandemic will create stratification in the industry that will require executives to take bold steps, rather than conservative ones, to achieve growth, Ernst & Young says in its inaugural life sciences quarterly report.

read more

Altarum: March health spending rebounds by double digits from drop in same month in 2020

Healthcare spending rebounded in March, growing by 12.5% above March 2020 spending levels that dropped due to the pandemic.

read more